{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-088200","form_type":"8-K","ticker":"IDYA","cik":"0001676725","company_name":"IDEAYA Biosciences, Inc.","filed_at":"2024-07-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.071948+00:00","generated_at":"2026-05-31T14:25:10.765622+00:00","sec_items":["1.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"IDEAYA enters option/license deal with Biocytogen for B7H3/PTK7 BsADC; total potential $406.5M","bullets":["Total potential payments of $406.5M including $100M development/regulatory milestones and single-digit royalties.","Option for exclusive worldwide license; upfront and option exercise fees up to $6.5M.","Targets B7H3/PTK7 co-expression in lung, colorectal, head and neck cancers with double-digit prevalence.","Development candidate nomination targeted for H2 2024; potential combo with DDR pipeline including IDE161 (PARG)."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-088200","json":"https://secwatch.observer/filing/0000950170-24-088200.json","markdown":"https://secwatch.observer/filing/0000950170-24-088200.md","text":"https://secwatch.observer/filing/0000950170-24-088200.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1676725/000095017024088200/0000950170-24-088200-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1676725/000095017024088200/idya-20240730.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T14:25:10.765622+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}